Updated October 2020
The 2020 Patient Assistance & Reimbursement Guide has the most up-to-date information on cancer drug assistance and reimbursement programs to help your patients alleviate the financial burden of their treatment.
This guide to financial assistance contains directions on program enrollment from 40 companies, granting eligible insured, underinsured, and uninsured patients access to more than 150 oncology medications at little or no cost, including new programs for Daiichi Sanyko and Epizyme, Inc.
The October 2020 update contains:
This PDF updates the print 2020 Patient Assistance & Reimbursement Guide, which was mailed to ACCC members in January 2020.
Email your comments and feedback to Maddelynne Parker, ACCC Content Coordinator.
Financial Toxicity Navigation Process Improvement
Financial Toxicity: A Conversation with Yousuf Zafar, MD, MHS, and Dan Sherman, MA, LPC
Financial Counselors: A Must-Have in Oncology
Accessing Co-Pay Assistance Opportunities
COVID-19 Financial Advocacy Resources
Our Financial Advocacy Boot Camp offers a dynamic online curriculum that helps you and your cancer patients navigate the complex healthcare system and pay for their treatment. Learn more about how to be an effective financial advocate.
The ACCC Oncology Drug Database contains billing and diagnosis codes, reimbursement amounts, FDA-approved indications, and contact information for every cancer drug on the market.
Access the Database